Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Lew

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2008
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD studyChristopher F McNicoll, Jeanne C Latourelle, Marcy E MacDonald, et al.
Human Genetics|July 1, 2008
Replication of association between ELAVL4 and Parkinson disease: the GenePD studyAnita L DeStefano, Jeanne Latourelle, Mark F Lew, et al.
BMC Medicine|November 7, 2008
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD studyJeanne C Latourelle, Mei Sun, Mark F Lew, et al.
JAMA Neurology|March 26, 2014
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit, M Flint Beal, David Oakes, et al.
Pageof 5